Literature DB >> 19133226

Active 1918 pandemic flu viral neuraminidase has distinct N-glycan profile and is resistant to trypsin digestion.

Zhengliang L Wu1, Cheryl Ethen, Gregg E Hickey, Weiping Jiang.   

Abstract

The 1918 pandemic flu virus caused one of the most deadly pandemics in human history. To search for unique structural features of the neuraminidase from this virus that might have contributed to its unusual virulence, we expressed this enzyme. The purified enzyme appeared as a monomer, a dimer and a tetramer, with only the tetramer being active and therefore biologically relevant. The monomer and the dimer could not be oligomerized into the tetramer in solution, suggesting that some unique structural features were required for oligomerization and activation. These features could be related to N-glycosylation, because the tetramer displayed different N-glycans than the monomer and the dimer. Furthermore, the tetramer was found to be resistant to trypsin digestion, which may give the virus the capability to invade tissues that are normally not infected by influenza viruses and make the virus more robust for infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133226     DOI: 10.1016/j.bbrc.2008.12.139

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Core-6 fucose and the oligomerization of the 1918 pandemic influenza viral neuraminidase.

Authors:  Zhengliang L Wu; Hui Zhou; Cheryl M Ethen; Vernon N Reinhold
Journal:  Biochem Biophys Res Commun       Date:  2016-03-21       Impact factor: 3.575

2.  Influenza A surface glycosylation and vaccine design.

Authors:  Chung-Yi Wu; Chih-Wei Lin; Tsung-I Tsai; Chang-Chun David Lee; Hong-Yang Chuang; Jhih-Bin Chen; Ming-Hung Tsai; Bo-Rui Chen; Pei-Wen Lo; Chiu-Ping Liu; Vidya S Shivatare; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-27       Impact factor: 11.205

3.  Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.

Authors:  Lalitha Venkatramani; Eric S Johnson; Gundurao Kolavi; Gillian M Air; Wayne J Brouillette; Blaine H M Mooers
Journal:  BMC Struct Biol       Date:  2012-05-06

4.  Glycosylation site alteration in the evolution of influenza A (H1N1) viruses.

Authors:  Shisheng Sun; Qinzhe Wang; Fei Zhao; Wentian Chen; Zheng Li
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

Review 5.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

6.  Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses.

Authors:  Shisheng Sun; Qinzhe Wang; Fei Zhao; Wentian Chen; Zheng Li
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

Review 7.  Homology modelling and spectroscopy, a never-ending love story.

Authors:  Hanka Venselaar; Robbie P Joosten; Bas Vroling; Coos A B Baakman; Maarten L Hekkelman; Elmar Krieger; Gert Vriend
Journal:  Eur Biophys J       Date:  2009-08-29       Impact factor: 1.733

8.  Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season.

Authors:  Deena R Blumenkrantz; Thomas Mehoke; Kathryn Shaw-Saliba; Harrison Powell; Nicholas Wohlgemuth; Hsuan Liu; Elizabeth Macias; Jared Evans; Mitra Lewis; Rebecca Medina; Justin Hardick; Lauren M Sauer; Andrea Dugas; Anna DuVal; Andrew P Lane; Charlotte Gaydos; Richard Rothman; Peter Thielen; Andrew Pekosz
Journal:  Virus Evol       Date:  2021-06-04

9.  The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase.

Authors:  Wentian Chen; Yaogang Zhong; Yannan Qin; Shisheng Sun; Zheng Li
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

10.  The Mechanism by which 146-N-Glycan Affects the Active Site of Neuraminidase.

Authors:  Pi Liu; Zhonghua Wang; Lijie Zhang; Dongmei Li; Jianping Lin
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.